Dear Reader,
Data about oneself has become a hot commodity, and, also, one that I cherish. This feeble realization did not just occur to me, but I think about it now as I have recently received my results from the Everlywell Food Sensitivity test. As the name implies, the test measures one’s immune response (more specifically, antibody reactivity) to a small battery of foods. (Note that…
Is Everlywell a reasonable testing choice for you? We put Everlywell trying and administrations under serious scrutiny. We portray the entire customer experience in this post so you realize what to expect. We likewise examine how its tests contrast with your other wellbeing testing options.
It is a common experience of discomfort when you have to go to clinic for tests. One may even regret the experience. At times when the test is quite personal level and lifesaving. These desperate times when we have to travel to the clinic or hospital and go through a distress.
Always thinking about one thing that if there would be a way to get the test done in the comfort of our home where we could do it alone and no one’s presence specially no one there to check on the results if the results are immediate. That is open secret behind Everlywell. It’s a test home collection kit. Its producers claims to be providing the discreet for home testing kit for over 30 tests for following categories
Is Everlywell a reasonable testing choice for you? We put Everlywell trying and administrations under serious scrutiny. We portray the entir
The new parent company, Everly Health, will remain headquartered in Austin and will have a telehealth network in all 50 states. The newly acquired companies, PWNHealth and Home Access Health Corporation, will join Everlywell as subsidiaries of Everly Health.
Healthtech startup Everlywell specialized in home testing announces $175M Series D
- By Nuadox Crew -
Austin, Texas-based Everlywell, a health tech startup known for its home testing kits, today announced an oversubscribed Series D financing of $175 million.
Video: “Everlywell - Easy and Affordable At-Home Lab Testing” by Everlywell, YouTube.
New investors participating in the round include funds and accounts managed by BlackRock, The Chernin Group (TCG), Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures, and Portfolia, as well as existing investors Goodwater Capital, Highland Capital Partners, and Next Coast Ventures. This investment brings the total capital raised by the company to over $250 million to date, which includes a Series C round led by Highland Capital Partners earlier this year.
The company plans to use the funds to expand its virtual care offerings, scale its testing and infrastructure, drive clinical research and disease management through testing, and grow its national leadership position in the at-home testing market.
Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health needs, Everlywell's total sales are projected to quadruple in 2020, with sales of most of its tests growing well over 100% year-over-year, aided in part by the expansion of its retail footprint to more than 10,000 locations, with distribution at Target, Walgreens, CVS, and Kroger stores nationwide.
In addition to receiving the first FDA emergency use authorization of its kind for its COVID-19 Test Home Collection Kit in May, Everlywell's enterprise line of business has also expanded significantly, closing over 100 deals with workplaces, universities, clinics, and government offices in 2020. Partnerships with leading diagnostics firms including Exact Sciences and major health plans such as Humana have created affordable and innovative testing solutions for preventative care, clinical research, and workforce testing.
Everlywell believes Americans deserve access to affordable lab tests and insightful, digitally-enabled results with actionable next steps. The company connects individuals to certified labs offering a suite of validated lab tests including Cholesterol, Heart Health, Fertility, STIs, Lyme Disease, Testosterone, Thyroid and more. Everlywell offers one of the only FDA-authorized at-home sample collection test kits for COVID-19, and was the first to provide access to at-home sample collection lab tests for fertility, high-risk HPV, and indoor & outdoor allergies. Prices are straightforward starting at $49 and tests are generally covered by Flexible Spending and Health Savings Accounts. Physician-reviewed, actionable test results from CLIA-certified labs are provided within days of sample receipt. The company also provides testing and engagement programs for health plans, healthcare organizations, and employers, including some of the largest health plans in the nation.
Source: Everlywell
Read Also
LetsGetChecked raises $12M, aiming to bring personal health tests to the masses
